A new invention of the Institute of Chemical
Technology ITEC Brazi was awarded the
silver medal of the 8rd International
Salon of Industrial Property ARCHIMEDES,
Moscow (15 – 18th March 2005) and also of the
33rd International Exhibition of Inventions,
New Techniques and Products Geneva (6 – 10th April
2005).
The inventions refers to a new product named HEPATOSTOP
which is used in the treatment of viral hepatites
A, B, C. This product reduces significantly the
transaminases down to their normal values even
during the first month of treatment.
The reduction of alanine transaminase (ALT) after
two month of treatment is presented in the following
table:
| ALT
(before treatment) |
ALT
(after two month treatment) |
| 140
units/l |
45 units/l |
| 109
units/l |
53 units/l |
HEPATOSTOP stimulates the production of Interferon
in the organism, it can be used also in the treatment
of inflammatory processes; it has also an antioxidant
power 150 times bigger than vitamin E. The Interferon
treatment of viral hepatites and HIV involves
many serious side effects (loss of hair, skin
diseases, profound depression etc.). Using HEPATOSTOP
not only saves the patients from these side effects
but it’s much cheaper.
HEPATOSTOP can be administrated orally, by suppository
or by injections.
The next step for our Institute is to produce
HEPATOSTOP on a larger scale, and for this we
are looking for sponsors.
Dr.
Eng. Diana Andrei and
Dr. Eng.
Constantin Andrei
Institute of Chemical Technology ITEC Brazi
CP 5, OP 1, Ploiesti, ROMANIA
Tel/Fax: 0040 244. 513.020, email:
|
